Perspectives on CNS clinical measurement
Thought leadership on endpoint strategy, digital assessment technology, regulatory science, and the challenges of measuring treatment effects in the most complex organ system.
Coming Soon
We are preparing our first series of articles. Sign up to be notified when new content is published.
Upcoming Topics
Why CNS Clinical Trials Fail: The Measurement Problem Nobody Talks About
Most CNS trial failures are attributed to the drug. Often, it is the endpoint that failed first.
Digital Endpoints in Neurology: Beyond the Hype
Separating the promise from the reality of digital biomarkers in neurological clinical trials.
The Case for Phase 1 Endpoint Strategy
Why the most impactful endpoint decisions happen before your first efficacy trial.
Central Rater Committees: An Underappreciated Quality Control
How rater variability silently degrades your endpoint data, and what to do about it.
Quantifying Fine Motor Function: What Kinematic Data Reveals
A technical perspective on what 240Hz sampling and multidimensional kinematic capture can see that clinical scales cannot.
Have a question about CNS measurement?
We are always happy to discuss clinical measurement challenges. Reach out and let us know what topics you would like us to cover.
Get in Touch